Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- Type
- Expression of concern
- Notice date
- 1/17/2022 0:00
- Journal
- Frontiers in Medicine
- Publisher
- Frontiers
- Notice DOI
- 10.3389/fmed.2021.831449
- Original paper DOI
- 10.3389/fmed.2021.668698